M. L. Rush

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Bortezomib for Relapsed/Refractory Acute Myeloid Leukemia

A. Advani, M. Sekeres, M. Kalaycio, 2012 .

A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia.

J. Maciejewski, M. Egorin, Y. Saunthararajah, 2010, Leukemia research.

A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid Leukemia.

F. Ali-Osman, W. Tse, J. Maciejewski, 2020, Clinical lymphoma, myeloma & leukemia.